Corcept Therapeutics' (CORT) CEO Joseph Belanoff On Q1 2017 Results Earnings Call Transcript

Reference #18.8c912f17.1556120837.c06f3a4b

Source : https://www.nasdaq.com/aspx/call-transcript.aspx?StoryId=4217444&Title=corcept-therapeutics-incorporated-cort-ceo-joseph-belanoff-on-q3-2018-results-earnings-call-transcript

Corcept Therapeutics Incorporated (CORT)
Corcept Therapeutics' (CORT) CEO Joseph Belanoff on Q1 2017 Results - Earnings Call Transcript
Corcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2016 Financial Results; Increases 2017 Revenue Guidance
Why Corcept Therapeutics Incorporated Shares Dipped
Corcept Therapeutics Announces Second Quarter 2018 Financial Results and Stock Repurchase Program; Provides Clinical Update
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2018 Preliminary Selected Financial Results; Provides 2019 Revenue Guidance
Corcept Therapeutics Announces Poster Presentations at the 2019 Annual Meeting of the Endocrine Society Meeting
Corcept Therapeutics' (CORT) CEO Joseph Belanoff on Q1 2014 Results - Earnings Call Transcript